Literature DB >> 7859838

HCV, HIV, HBV and HDV infections in intravenous drug addicts.

R C Coppola1, P E Manconi, R Piro, M L Di Martino, G Masia.   

Abstract

Hepatitis viruses and the acquired immunodeficiency viruses often infect intravenous drug addicts (IVDAs). Our study includes 255 IVDAs (26 females and 229 males, aged 20-35 years) from Cagliari. Of 255 subjects examined, 207 (81.1%) were positive for anti-HCV and 84 (32.9%) for anti-HIV. Nineteen (7.4%) subjects were HBsAg carriers, and 12 of these (63%) had an HDV superinfection. Markers of previous HBV infections were tested in 223 cases and 137 (61.4%) were found positive; of these 14 (10.2%) also had HDV infection. Of the 223 drug addicts examined for all infection markers, 18 (8%) were negative to all markers, 46 (20.6%) were positive to only one, 89 (39.9%) were positive to two, 64 (28.7%) to three and 6 (2.6%) were positive to all. Subjects with a single infection were significantly fewer than those with multiple infections. The correlations studied among the various markers did not point out any statistically significant associations. Even so, a previous HBV infection was more common while active HBV/HDV infections were less common among subjects with anti-HCV; HDV infection was more common among HIV-positive subjects. In HBsAg carriers neither HBV-DNA nor HCV-RNA was detected; HCV-RNA was found more frequently in anti-HIV positive subjects than in subjects with the anti-HCV isolate.

Entities:  

Mesh:

Year:  1994        PMID: 7859838     DOI: 10.1007/bf01719350

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  8 in total

1.  Correlation of hepatitis C virus antibodies with HIV-1 seropositivity in intravenous drug addicts.

Authors:  H P Huemer; W M Prodinger; C Larcher; L Möst; M P Dierich
Journal:  Infection       Date:  1990 Mar-Apr       Impact factor: 3.553

2.  An immunoassay for specific amplified HCV sequences.

Authors:  L Imberti; E Cariani; A Bettinardi; A Zonaro; A Albertini; D Primi
Journal:  J Virol Methods       Date:  1991-10       Impact factor: 2.014

3.  Sexual transmission of hepatitis C virus: cohort study (1981-9) among European homosexual men.

Authors:  M Melbye; R J Biggar; P Wantzin; K Krogsgaard; P Ebbesen; N G Becker
Journal:  BMJ       Date:  1990-07-28

4.  Hepatitis B virus infection in the acquired immunodeficiency syndrome.

Authors:  V K Rustgi; J H Hoofnagle; J L Gerin; E P Gelmann; C M Reichert; J N Cooper; A M Macher
Journal:  Ann Intern Med       Date:  1984-12       Impact factor: 25.391

5.  High incidence of hepatitis B infection and evolution of chronic hepatitis B infection in patients with advanced HIV infection.

Authors:  C Homann; K Krogsgaard; C Pedersen; P Andersson; J O Nielsen
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1991

6.  DNA enzyme immunoassay: general method for detecting products of polymerase chain reaction.

Authors:  G Mantero; A Zonaro; A Albertini; P Bertolo; D Primi
Journal:  Clin Chem       Date:  1991-03       Impact factor: 8.327

7.  Sexual transmission of hepatitis C virus and its relation with hepatitis B virus and HIV.

Authors:  J Tor; J M Llibre; M Carbonell; R Muga; A Ribera; V Soriano; B Clotet; M Sabriá; M Foz
Journal:  BMJ       Date:  1990-11-17

8.  Detection of hepatitis C viral sequences in blood donations by "nested" polymerase chain reaction and prediction of infectivity.

Authors:  J A Garson; R S Tedder; M Briggs; P Tuke; J A Glazebrook; A Trute; D Parker; J A Barbara; M Contreras; S Aloysius
Journal:  Lancet       Date:  1990-06-16       Impact factor: 79.321

  8 in total
  6 in total

1.  Prevalence of hepatitis C among injection drug users in England and Wales: is harm reduction working?

Authors:  V D Hope; A Judd; M Hickman; T Lamagni; G Hunter; G V Stimson; S Jones; L Donovan; J V Parry; O N Gill
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

2.  HCV status knowledge and risk behaviours amongst intravenous drug users.

Authors:  G Vidal-Trécan; J Coste; I Varescon-Pousson; B Christoforov; A Boissonnas
Journal:  Eur J Epidemiol       Date:  2000-05       Impact factor: 8.082

Review 3.  Epidemiology and control of hepatitis B infection: a perspective from the Philippines, Asia.

Authors:  M A Lansang
Journal:  Gut       Date:  1996       Impact factor: 23.059

4.  Response to hepatitis A and B vaccine alone or in combination in patients with chronic hepatitis C virus and advanced fibrosis.

Authors:  Erik Seth Kramer; Charlotte Hofmann; Paula G Smith; Mitchell L Shiffman; Richard K Sterling
Journal:  Dig Dis Sci       Date:  2009-06-11       Impact factor: 3.199

5.  Prevalence of hepatitis C virus and HIV infection among injection drug users in two Mexican cities bordering the U.S.

Authors:  Emily Faye White; Richard S Garfein; Kimberly C Brouwer; Remedios Lozada; Rebeca Ramos; Michelle Firestone-Cruz; Saida G Pérez; Carlos Magis-Rodríguez; Carlos J Conde-Glez; Steffanie A Strathdee
Journal:  Salud Publica Mex       Date:  2007 May-Jun

6.  Prevalence of human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infection among heroin injectors in the central region of Saudi Arabia.

Authors:  Abdulaziz T Alshomrani
Journal:  Saudi Med J       Date:  2015-07       Impact factor: 1.484

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.